By Ben Glickman Regeneron Pharmaceuticals and Sanofi's Dupilumab received approval from the U.S. Food and Drug Administration for a treatment of an esophagus.
By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with hypoplastic left.
Meta has faced a torrent of condemnation over the effects of its content on younger users, prompting Salesforce CEO Marc Benioff and others to compare the.